Related by context. All words. (Click for frequent words.) 70 MAGE A3 68 HER2/neu 68 GPNMB 67 CD# antigen 66 carcinoembryonic antigen 66 HER-2/neu 66 huC# DM4 66 tumor antigen 66 epithelial tumors 66 TTR gene 65 tumor specific antigen 65 K ras mutations 65 acid phosphatase PAP 65 Mesothelin 65 EpCAM 65 WT1 65 CanAg 64 NY ESO 64 HER2 expression 64 HAAH 64 mesothelin 64 BRAF mutation 64 gastric adenocarcinoma 63 cytokeratin 63 Immunohistochemical analysis 63 MLL AF9 63 LHRH 63 folate receptor 63 somatostatin receptors 63 EGFR protein 63 HER2/neu protein 63 TRAIL R2 63 hCG β 63 thyroglobulin 63 LHRH receptors 63 epithelial cells lining 63 CD# molecule 63 B7 H3 62 HCV replicon 62 PC3 cells 62 IgM isotype 62 lymphocytosis 62 colorectal carcinomas 62 peripheral blood mononuclear 62 A3 adenosine receptor 62 adenoviral 62 EGFr 62 RRM1 62 tumorigenicity 62 surface glycoprotein 62 TNFa 62 HBsAg 62 iNOS 62 HER2 receptor 61 L1 CAM 61 EGFRvIII 61 GRNVAC1 61 androgen receptor AR 61 PSMA ADC 61 PSMA protein 61 MUC1 protein 61 MAGE A3 protein 61 HGPIN 61 EphB4 61 azacytidine 61 breast carcinomas 61 VSV G 61 specific membrane antigen 61 aT cell 61 HEK# cells 61 pT2 61 FLT3 61 luteinizing hormone releasing 61 HepG2 cells 61 hCG beta 61 Trp p8 61 Her2/neu 61 colon carcinoma 61 cell adhesion molecule 61 TGF alpha 61 T#I [002] 61 AGTR1 61 SOD1 gene 60 Enzastaurin 60 prostate adenocarcinoma 60 hA# 60 vimentin 60 liver metastases 60 papillary renal cell carcinoma 60 HER2 overexpression 60 myelodysplastic myeloproliferative diseases 60 CLL SLL 60 TIMP 60 neuroblastoma tumors 60 castrate resistant 60 IgG antibodies 60 glioma cells 60 humanized antibody 60 antibody titer 60 Annexin V 60 Epidermal Growth Factor Receptor 60 annexin V 60 fallopian tube cancers 60 hTERT 60 T1c 60 HER2 neu 60 colorectal carcinoma 60 HER2 ErbB2 60 leukemia AML 60 thymidine kinase 60 ovarian carcinoma 60 TNFR1 60 EGFR HER2 60 IGFBP 3 60 metastatic colorectal 60 neoplastic cells 60 prostate carcinoma 60 metastatic colorectal carcinoma 60 Clusterin 60 recurrent glioblastoma multiforme 60 oral prodrug 60 thyroid carcinomas 60 tumors GIST 60 binds selectively 60 immunohistochemical staining 60 HER2 protein 60 DLL4 60 precursor lesions 60 alvespimycin 60 M2 subunit 60 RAV# 60 peptide antigens 60 malignant ascites 59 HER2 amplification 59 CD# + [001] 59 GSTP1 59 tumor xenografts 59 metastatic neuroendocrine tumors 59 interleukin IL -# 59 LHRH receptor positive 59 Aflibercept 59 promoter methylation 59 V#F 59 TNF α 59 humanized monoclonal antibodies 59 MET amplification 59 antibody MAb 59 SPINK1 59 metastatic malignant 59 stage IIIb IV 59 MVA MUC1 IL2 59 HBeAg positive patients 59 MUC1 59 cMET 59 skeletal metastases 59 metastatic melanomas 59 inducible nitric oxide synthase 59 pDCs 59 generation antisense inhibitor 59 prostate cancer CaP 59 intratumoral injection 59 AAV2 59 p# antigen 59 multiple myeloma MM 59 inhibitory receptor 59 irreversible inhibitor 59 metastatic gastric 59 Proxinium TM 59 trastuzumab Herceptin ® 59 pancreatic adenocarcinoma 59 CD# receptor 59 IFN gamma 59 hENT1 59 Monocyte 59 5alpha reductase 59 orally administered inhibitor 59 activated lymphocytes 59 protein antigens 59 Lymph node 59 pDC 59 cytotoxin 59 T#I mutation 59 PC# cells 59 antigen CD# 59 specific antigen 59 interferon γ 59 VEGFR 59 nucleolin 59 BRAF V#E mutation 59 P selectin 59 paclitaxel cisplatin 59 Ki# 59 mRCC 59 CYT# potent vascular disrupting 59 ELISPOT 58 MGd 58 TRAIL Receptor 58 isotype 58 neovasculature 58 colorectal adenocarcinoma 58 galiximab 58 MVA BN ® 58 IFN γ 58 VEGFR1 58 chemokine receptor 58 anthracycline chemotherapy 58 KIT mutations 58 immunoblotting 58 EphA2 58 demonstrated antitumor activity 58 radiolabeled 58 intercellular adhesion molecule 58 metastatic malignant melanoma 58 immunogen 58 ERCC1 58 interferon IFN 58 bleomycin 58 hepatoma 58 extracellular domain 58 radiotherapeutic 58 Dacogen decitabine 58 Tubulin 58 alpha folate receptor 58 OMP #M# 58 nonmetastatic 58 #I TM# 58 c myc 58 hPAM4 58 sipuleucel T 58 hepatocellular carcinomas 58 denileukin diftitox 58 matrix metalloproteinases 58 KRAS mutations 58 MAGE A3 ASCI 58 pancreatic ovarian 58 gastrointestinal stromal tumors GISTs 58 immunostaining 58 mutational status 58 nodal metastasis 58 HBeAg negative 58 TIMP 1 58 chronic eosinophilic leukemia 58 NSCLC tumors 58 EGFR TKI 58 TOP2A 58 EGFP 58 busulfan 58 hCG Beta 58 prostate cancer antigen prostatic 58 progesterone receptor negative 58 p#HER# 58 SNT-MC#/idebenone 58 KRAS mutation 58 HER2 negative 58 milatuzumab 58 PDGFR 58 carcinoma HCC 58 hypereosinophilic syndrome 58 gene amplification 58 invasive carcinoma 58 EGFR mutations 58 Irinotecan 58 renal cysts 58 eIF4E 58 apical membrane 58 receptor CXCR4 58 specific lectin receptors 58 E#F# 58 VEGFR2 58 pancreatic endocrine 58 PCA3 gene 58 tryptase 58 anaplastic lymphoma kinase ALK 58 annexin 58 glutamic acid decarboxylase 58 endoglin 58 antigen 58 hormone LHRH 58 ERK1 2 57 complete cytogenetic response 57 IL 1ß 57 constitutively active 57 alveolar epithelial cells 57 receptor tyrosine kinase inhibitor 57 survivin 57 epithelial cancers 57 enkephalin 57 neuroendocrine cancers 57 cervical intraepithelial neoplasia 57 pancreatic prostate 57 diagnostic biomarker 57 replicon 57 bcl 2 57 targeting CD# 57 recombinant adeno associated 57 HGS ETR2 57 retinoic acid receptor 57 metastatic pancreatic 57 estrogen receptor ER 57 splice variants 57 Bezielle 57 lung metastases 57 VP# [004] 57 subcutaneous immunoglobulin 57 XL# inhibits 57 envelope glycoprotein 57 LHRH receptor 57 nanomolar 57 Gleevec resistant 57 HER2 positive metastatic breast 57 xenografts 57 IgG1 monoclonal antibody 57 PKCi 57 transfected 57 ALDH 57 human chorionic gonadotropin hCG 57 NOD SCID mice 57 anti apoptotic proteins 57 bispecific antibody 57 myeloproliferative diseases 57 heparanase 57 monocytes macrophages 57 ERBB2 57 mutated K ras 57 florbetaben 57 castration resistant prostate cancer 57 fluoropyrimidine 57 Her2 57 colorectal gastric 57 syngeneic 57 CCL# 57 PBMCs 57 K#R [002] 57 untreated metastatic melanoma 57 Exherin TM 57 cytochrome P 57 malignant prostate 57 pan HDAC inhibitor 57 oxysterols 57 co stimulatory molecules 57 SSc 57 depsipeptide 57 CTAP# Capsules 57 NQO1 57 vinca alkaloid 57 TRAIL receptor 57 HBeAg 57 CD# CD# 57 Vidaza azacitidine 57 lutetium plus 57 HIF 1alpha 57 mouse xenograft models 57 protein tyrosine phosphatase 1B 57 cisplatin resistant 57 cytoreduction 57 IGF IR 57 CD# [002] 57 VEGF receptor 57 c MYC 57 HER2 57 synovial tissue 57 CD4 receptor 57 myeloperoxidase 57 imatinib Gleevec 57 humanized monoclonal antibody 57 Aurora kinase 57 Bortezomib 57 herpesviruses 57 viral antigens 57 dasatinib Sprycel ® 57 lymphoid malignancies 57 progesterone receptors 57 antigens 57 supernatants 57 PDGF B 57 adenocarcinomas 57 Transgenic Mice 57 leukaemias 57 bronchial epithelial cells 57 GRP# 57 KRAS oncogene 57 TLR7 agonist 57 recurrent metastatic 57 caveolin 1 57 metaglidasen 57 EGF receptor 57 IgM antibodies 57 monocyte chemoattractant protein 57 proto oncogene 57 mutated BRAF gene 57 sunitinib Sutent 57 GI mucosa resulting 57 serum antibody 57 bladder ovarian 57 prostate epithelial cells 56 vWF 56 CXCR4 56 metastatic GIST 56 eIF 4E 56 Leydig cells 56 idiopathic membranous nephropathy 56 receptor blocker 56 multidrug resistance 56 Epratuzumab 56 CCR9 56 PKC# 56 SGLT 56 TRAIL receptors 56 Vicinium TM 56 pmol L 56 metastatic prostate 56 Western blotting 56 metastatic carcinoma 56 antibody titers 56 alkylating agents 56 mammaglobin 56 MGMT gene 56 immunoreactivity 56 patients evaluable 56 alkylating agent 56 CD# + [002] 56 methicillin sensitive 56 miR #a [001] 56 TAp# 56 transfected cells 56 targeted radiotherapeutic 56 adjuvant cisplatin 56 relapsed leukemia 56 gastrointestinal stromal tumor GIST 56 LNCaP cells 56 Factor Receptor 56 E. faecalis 56 Notch receptors 56 uPAR 56 IgM 56 HER2/neu gene 56 pancreatic carcinoma 56 oblimersen 56 constitutively 56 FUS1 56 saline placebo 56 Alphanate R 56 CCN2 56 BCR ABL protein 56 bevacizumab Avastin ® 56 CD#b 56 compound AEZS 56 Modified Vaccinia Ankara 56 IMA# 56 alfa 2a 56 pediatric acute lymphoblastic 56 cyclin dependent kinase 56 potent cytotoxic 56 intraepithelial neoplasia 56 transmembrane protein 56 rabbit polyclonal 56 bovine thrombin 56 gastric carcinomas 56 CCR1 56 thioredoxin 56 hormone LHRH antagonist 56 stably transfected 56 pretransplant 56 activin 56 CD#c 56 TroVax ® 56 ELISpot 56 chemokine receptors 56 novel VDA molecule 56 proteinase 56 IGF 1R 56 RANTES 56 mRNA transcripts 56 LymphoStat B belimumab 56 HLA DR 56 liposomal doxorubicin 56 short hairpin RNA 56 E selectin 56 BMP2 56 tyrosine kinase receptor 56 humoral responses 56 BARACLUDE ® 56 Kinase Inhibitor 56 IL #R 56 lymphomas leukemias 56 CEACAM1 56 Akt activation 56 transgenic rats 56 IAP inhibitor 56 Trastuzumab Herceptin 56 OncoVEX GM CSF 56 potently inhibited 56 Tumor Necrosis Factor 56 Pharmacokinetics PK 56 malignant pleural mesothelioma 56 gastric carcinoma 56 colorectal pancreatic 56 NeoLipid R 56 TLR9 agonist 56 neutralizing antibody 56 vidofludimus 56 HER2 positive cancers 56 OMP #R# 56 glucocerebrosidase GCD 56 Chemokine Receptor 56 MAb 56 EGFR expression 56 ErbB 56 PI3K inhibitor 56 MMP9 56 non nucleoside inhibitor 56 cyclin E 56 IgG1 antibody 56 phosphoprotein 56 Ceflatonin 56 pancreatic lung 55 proteolytic cleavage 55 Aplidin 55 Epstein Barr Virus EBV 55 alkaline phosphatase 55 KSHV 55 NF kB pathway 55 trophoblast cells 55 PI3K inhibitors 55 neutralizing antibodies 55 thymidylate synthase TS 55 IL 1beta 55 carbohydrate antigens 55 refractory chronic lymphocytic 55 selective inhibition 55 CCR2 55 Cytotoxic T 55 adhesion molecule 55 MyVax R 55 FGFR1 55 telomerase reverse transcriptase 55 #beta 55 EGF receptors 55 Degarelix 55 anti PlGF 55 anti HBs 55 Janus kinase 55 E7 proteins 55 cell lymphoma CTCL 55 mouse mammary tumor 55 chlorambucil 55 chemoresistant 55 cathepsin B 55 Oncolytic 55 natriuretic peptide 55 poly ADP ribose polymerase 55 chlamydial 55 selective modulator 55 Activating mutations 55 agonistic human 55 CTGF 55 HERCEPTIN 55 mRNA expression 55 downregulated 55 thrombin receptor 55 melanoma antigens 55 mCRC patients 55 PDGF receptor 55 NS4A 55 plasmid encoding 55 investigational monoclonal antibody 55 IgA antibodies 55 LRP6 55 INGN 55 gp# protein [002] 55 FOLFOX6 55 ERalpha 55 Î ² 55 isoform 55 monoclonal 55 cetuximab Erbitux R 55 fusion proteins 55 soluble tumor necrosis 55 ribonucleotide reductase clinically validated 55 induces apoptosis 55 cyclin D1 55 NRTI resistance 55 FGFR2 55 FSH receptor 55 serotonin 2C receptor 55 lentiviral vector 55 tissue transglutaminase 55 Kupffer cells 55 HbF 55 neuroblastoma cells 55 immunoglobulin G 55 hepatitis C HCV 55 TNFalpha 55 GRN# 55 iobenguane 55 monoclonal antibody IgG1 Mab 55 chlamydial infection 55 mediated inhibition 55 nucleotide analog 55 vinorelbine tartrate 55 Cytomegalovirus CMV 55 MDSCs 55 Eg5 55 virus AAV 55 metastatic bladder 55 cytotoxic T lymphocyte 55 Fibroblast Growth Factor Receptor 55 bladder carcinoma 55 P#X# 55 pathophysiological effects 55 BALB c mice 55 effector function 55 Cre recombinase 55 BCG refractory 55 galectins 55 cancer mCRC 55 CD# protein 55 MDR1 55 autoantibodies 55 granzyme B 55 nucleoside analog 55 p# mutation 55 RASSF1A 55 constitutively activated 55 Survivin 55 μg ml 55 haematopoietic 55 hypermethylated 55 PNP inhibitor 55 myeloma cells 55 Achieves Primary Endpoint 55 intradermal injection 55 PNT# 55 NKX#.# 55 chimeric monoclonal antibody 55 immunological responses 55 cells overexpressing 55 aurora kinase 55 mutant p# 55 idiotype 55 NPC 1C 55 idiotype protein 55 ErbB2 55 breast pancreatic 55 HPV# 55 virulence genes 55 TLR antagonist 55 splenocytes 55 microvascular endothelial cells 55 ALB # 55 alpha#beta# integrin 55 Elotuzumab 55 AT1R 55 Pgp 55 mutated KRAS 55 specific CD8 + 55 microglial activation 55 cells PBMC 55 apoptotic pathway 55 anastrazole 55 calcineurin inhibitor 55 serine protease 54 c KIT 54 hormone receptor positive 54 MyVax ® 54 TrkA 54 hypoxia inducible factor 54 Trofex 54 Luteinizing Hormone Releasing Hormone 54 cysteine protease 54 dimerization 54 epitope 54 CTAP# 54 Cloretazine 54 Sudhir Agrawal D.Phil 54 HIF 1a 54 tolerogenic 54 MKC# MT 54 cells PBMCs 54 systemically administered 54 MYCN 54 somatostatin receptor 54 NF kappaB activation 54 redox active 54 HER2 receptors 54 estrogen receptor 54 glycosylated 54 homodimer 54 highly immunogenic 54 Anticalins ® 54 endocrine therapies 54 TRAIL induced apoptosis 54 PhG alpha 1 54 targets Galectin receptors 54 PI3K Akt 54 lymphoid tissues 54 estrogen receptor progesterone receptor 54 CD4 + CD# 54 CD8 T cell 54 histone deacetylase HDAC 54 ALT normalization 54 DNA intercalator 54 seronegative 54 EGFR inhibitors 54 SPRYCEL ® 54 N cadherin 54 N. gonorrhoeae 54 oncoprotein 54 cytomegalovirus CMV 54 adenoviral vectors 54 receptor alpha 54 ELISPOT assay 54 somatic mutations 54 pancreatic islet 54 plasmid DNA 54 tumor antigens 54 EGFR activating mutations 54 CCL2 54 orthotopic model 54 pAkt 54 mutated KRAS gene 54 HBeAg negative patients 54 p# mitogen activated 54 EGFR HER 54 antibody MT# 54 CDK4 54 Sym# 54 p# INK4a 54 metastatic hormone refractory 54 IGFBP2 54 HDACi 54 ALK inhibitors 54 BCR ABL 54 GFAP 54 HSP# inhibitor 54 antiangiogenic agent 54 p#NTR 54 nestin 54 polyclonal 54 mutated p# 54 albumin bound paclitaxel 54 CD4 + T lymphocytes 54 heterologous 54 basolateral 54 HIV coinfected 54 haematopoietic stem cell 54 investigational immunotherapy 54 cyclin dependent kinase inhibitor 54 methylated DNA 54 IgG antibody 54 Tie2 54 Kinoid 54 etiologic agent 54 SIR Spheres 54 corticosteroid dexamethasone 54 adenoviral vector 54 EGFr expressing metastatic colorectal 54 essential thrombocythemia ET 54 lymphoid organs 54 chronic HBV 54 activating mutations 54 HER1 54 MDA MB 54 Plasmid DNA 54 TGF β 54 CsA 54 potent inducer 54 IDH mutations 54 Tarceva TM 54 CHO cells 54 adenovirus vectors 54 RhD positive 54 beta estradiol 54 cellular immunotherapy 54 c Src 54 4E BP1 54 PlGF 54 Rap1 54 Factor VIIa 54 IgM antibody 54 RANKL 54 TGF ß 54 CEQ# 54 Her-2/neu 54 EGFR 54 CDK inhibitor 54 tumor vasculature 54 PCR assay 54 evaluable patients 54 miR #b [001] 54 luciferase reporter 54 clusterin 54 hypermethylation 54 lymphoid cells 54 unresectable locally advanced 54 invasive lobular 54 sodium thiosulfate STS 54 GPR# [001] 54 intestinal epithelial cells 54 CLL cells 54 thyroid hormone receptor 54 Vacc 4x 54 basophils 54 immunostimulatory 54 GVAX R 54 Aurexis 54 VEGF induced 54 intranasal formulation 54 ADAMTS# 54 chronic myeloid 54 IGFBP 54 tNOX 54 HPV subtypes 54 Epidermal growth 54 somatostatin 54 cytoplasmic domain 54 GW# [003] 54 plasmacytoid dendritic cells 54 CTLs 54 antisense oligonucleotides 54 metalloproteinase 54 humoral immune response 54 polycythemia vera essential thrombocythemia 54 endothelial nitric oxide synthase 54 anti CD3 54 castration resistant 54 Alfacell proprietary ribonuclease 54 cytokines IL 54 IGF1R 54 murine 54 C#BL 6 mice 54 pentostatin 54 bactericidal activity 54 microglial 54 IL# [001] 54 relapsing remitting MS RRMS 54 varicella zoster virus VZV 54 alpha1 antitrypsin AAT deficiency 54 CMV disease 54 SCIg 54 PEGylated anti 53 Beta hCG 53 ABCB1 53 refractory acute myeloid 53 aplastic anemia AA 53 COL#A# 53 EGFR tyrosine kinase inhibitors 53 PTP 1B 53 FasL 53 outer membrane proteins 53 CD# expression [001] 53 CD8 + 53 HER3 53 Upregulation 53 transferrin 53 eNOS 53 forodesine 53 oligodendrocyte progenitor cells 53 elastase 53 achieved sustained virological 53 MVA BN 53 dsRNA 53 shRNAs 53 cytolytic 53 c Fos 53 stromal cells 53 constitutively expressed 53 siRNA therapeutic 53 receptor CCR5 53 Antigens 53 UPLYSO 53 NP2 53 cyclic AMP cAMP 53 estrogen receptor alpha 53 SGLT2 53 Vandetanib 53 #T# tumor 53 mAb 53 cetuximab Erbitux 53 tubulin polymerization 53 PPARgamma 53 virulence determinants 53 virus HCV protease inhibitor 53 GAP #B# 53 Epstein Barr virus EBV 53 Sapacitabine 53 interferon lambda 53 receptor tyrosine kinase 53 refractory gout 53 enzyme linked immunosorbent 53 selective agonist 53 IFN alpha 53 cytotoxic effects 53 B CLL 53 fusion protein 53 ovarian endometrial 53 proteoglycan 53 novel therapeutic antibodies 53 lysophosphatidic acid LPA 53 plasma kallikrein inhibitor 53 TGF ß1 53 urease 53 MEFs 53 imatinib Gleevec ® 53 thymidine 53 transgene expression 53 FGFR3 53 5 HT2A serotonin 53 unmutated 53 estrogen receptor beta 53 chemosensitizer 53 antisense oligonucleotide 53 heterodimers 53 NFκB 53 CXCL5 53 receptor inhibiting monoclonal 53 BRCA deficient 53 CXCR7 53 polysaccharide polymer 53 ER alpha 53 adefovir dipivoxil 53 homodimers 53 pamidronate 53 progesterone receptor 53 systemic anaplastic large 53 adalimumab Humira 53 mediated immunity 53 beta actin 53 cancer immunotherapeutics 53 refractory colorectal cancer 53 cytokine interleukin 53 refractory metastatic 53 radiation sensitizer 53 Zarnestra 53 DAVANAT 53 ABCG1 53 miRNA genes 53 solid tumors 53 selectively binds 53 MCSP respectively 53 ovarian breast 53 CXCL# 53 AAV vectors 53 claudin 53 Notch receptor 53 methionine aminopeptidase 53 lipohypertrophy 53 murine monoclonal antibody 53 cetuximab Erbitux ® 53 S#A# [002] 53 whose tumors overexpress 53 DNA plasmids 53 xenograft tumors 53 CXCR4 receptor 53 GPC3 53 GM CSF 53 TLR8 53 kinase inhibition 53 ESBLs 53 Stat5 53 P. gingivalis 53 interferon gamma 53 NS5b 53 HLA DQ2 53 ZNF# 53 adenovirus vector 53 Klebsiella pneumoniae 53 miR #a [002] 53 hormone receptor negative 53 HIF 1α 53 p#INK#a 53 Antigenics QS 53 Cyclin E 53 selectively inhibited 53 tipranavir ritonavir 53 p# deficient 53 Familial Adenomatous Polyposis FAP 53 IL2 53 castrate resistant prostate cancer 53 UsiRNAs 53 DCVax R 53 Glioblastoma Multiforme 53 novel peptide 53 immunotoxin 53 idiotype vaccines 53 HER-2/neu protein 53 K ras 53 receptor molecule 53 tyrosine kinase inhibitor 53 deacetylation 53 Bcr Abl 53 lentiviral 53 pyruvate kinase 53 IL 1β 53 biotinylated 53 NS3 53 anti EGFR antibody 53 activating mutation 53 isotypes